News for Healthier Living

New Clinical Trial at UTHealth Houston Tests Gene Therapy Vector That Delivers Drug Aimed at Stopping Overactive Bladder in Patients with Spinal Cord Injury

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.

March 12, 2025


March 13 2025

March 12 2025

March 11 2025

March 10 2025

March 9 2025

March 8 2025

March 7 2025

March 6 2025

March 5 2025

March 4 2025

March 3 2025

March 2 2025

February 28 2025

February 27 2025